BEROTERKIB ANHYDROUS
UNII 14FDK6ISC9

Substance Identification & Data

This profile provides standardized clinical and technical data for Beroterkib Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 14FDK6ISC9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2095719-92-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

14FDK6ISC9

CAS Registry Number

2095719-92-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BEROTERKIB ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H31ClFN5O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BVRGQPJKSKKGIH-PUAOIOHZSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C155785

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

129053037

Unique identification number in the NCBI database of chemical substances.

INN ID

13233

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C([C@@H](C)N1C(c2cc(ccc2C1)-c3nc(ncc3Cl)NC4CCOCC4)=O)(=O)N[C@H](CO)c5cc(cc(c5)OC)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Beroterkib Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BEROTERKIB [INN]

BEROTERKIB ANHYDROUS

Systematic Nomenclature

(.ALPHA.R)-6-(5-CHLORO-2-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-PYRIMIDINYL)-N-((1S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)-1,3-DIHYDRO-.ALPHA.-METHYL-1-OXO-2H-ISOINDOLE-2-ACETAMIDE

SYS

(2R)-2-(6-(5-CHLORO-2-((OXAN-4-YL)AMINO)PYRIMIDIN-4-YL)-1,3-DIHYDRO-2H-1-OXOISOINDOL-2-YL)-N-((1S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)PROPANAMIDE

SYS

(2R)-2-(6-(5-CHLORO-2-((OXAN-4-YL)AMINO)PYRIMIDIN-4-YL)-1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)-N-((1S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)PROPANAMIDE

SYS

(R)-2-(6-(5-CHLORO-2-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)PYRIMIDIN-4-YL)-1-OXOISOINDOLIN-2-YL)-N-((S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)PROPENAMIDE

SYS

2H-ISOINDOLE-2-ACETAMIDE, 6-(5-CHLORO-2-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-PYRIMIDINYL)-N-((1S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)-1,3-DIHYDRO-.ALPHA.-METHYL-1-OXO-, (.ALPHA.R)-

SYS